Skip to content
healthcare.dev

NEOSTIGMINE METHYLSULFATE

NDC 51662-1557, NEOSTIGMINE METHYLSULFATE, injection, from HF Acquisition Co LLC, DBA HealthFirst.

Product NDC
51662-1557
Status
Listed
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209933
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1557 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
51662-1557-35166215570310 POUCH in 1 CASE (51662-1557-3) / 1 CARTON in 1 POUCH (51662-1557-2) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c4be8467-7b7e-551d-e053-2995a90a3045

Use it

Look up 51662-1557 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1557 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51662-1557. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.